AMPLIFY-7P, a first-in-human safety and efficacy trial of adjuvant mKRAS-specific lymph node targeted amphiphile ELI-002 7P vaccine in patients with minimal residual disease-positive pancreatic and colorectal cancer Meeting Abstract
| Authors: | Devoe, C. E.; Pant, S.; Wainberg, Z. A.; Chung, V.; George, T. J.; Kasi, P. M.; VanWyk, H.; Tavares, A.; Perry, J.; Kheoh, T.; McNeil, L.; Welkowsky, E.; DeMuth, P.; Haqq, C. M.; O'Reilly, E. M. |
| Abstract Title: | AMPLIFY-7P, a first-in-human safety and efficacy trial of adjuvant mKRAS-specific lymph node targeted amphiphile ELI-002 7P vaccine in patients with minimal residual disease-positive pancreatic and colorectal cancer |
| Meeting Title: | 2024 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2024 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-06-01 |
| Language: | English |
| ACCESSION: | WOS:001275557400578 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2024.42.16_suppl.2636 |
| Notes: | Meeting Abstract: 2636 -- Source: Wos |
